Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical and genomic features in patients with second primary glioblastoma following first primary renal cell carcinoma.

BMC cancer - 30 Jan 2023

Zhang Guang-Tao, Liu Qi, Zuo Fu-Xing, Liu Hou-Jie, Wang Song-Quan, Yuan Qing, Liu Ang-Si, Hu Ke, Meng Xiao-Li, Wang Wei-Jia, Qian Hai-Peng, Wan Jing-Hai, Cai Hong-Qing

Abstract excerpt

PURPOSE: To explore the potential pathogenesis and clinical features of second primary glioblastoma (spGBM) following first primary renal cell carcinoma (fpRCC). METHODS: Patients with spGBM after fpRCC were enrolled from our institution and the SEER dataset. Sanger sequencing, whole genome sequencing, and immunehistochemistry were used to detect molecular biomarkers. RESULTS: Four and 122 cases from our...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Renal Cell

Share to Genomics

Share to Glioblastoma

Share to Kidney Neoplasms

Share to Mutation

Share to Prognosis

Source

Open in PubMed Open full text

Identifiers

PMID: 36717819
DOI: 10.1186/s12885-023-10541-x
PMCID: PMC9887896

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical and genomic features in patients with second primary glioblastoma following first primary renal cell carcinoma.PMID 36717819Read ↗

A longer time to relapse is associated with a larger increase in differences between paired primary and recurrent IDH wild-type glioblastomas at both the transcriptomic and genomic levels.Semantic proximity Read ↗

Genetic and clinical characteristics of primary and secondary glioblastoma is associated with differential molecular subtype distribution.Semantic proximity Read ↗

Primary and secondary gliosarcomas: clinical, molecular and survival characteristics.Semantic proximity Read ↗

Comparative analysis of molecular and histological glioblastomas: insights into prognostic variance.Semantic proximity Read ↗

Primary and secondary glioblastomas: from concept to clinical diagnosis.Semantic proximity Read ↗

Primary versus secondary gliosarcoma: a systematic review and meta-analysis.Semantic proximity Read ↗

Genetic pathways to primary and secondary glioblastoma.Semantic proximity Read ↗

Genomic alterations predictive of response to radiosurgery in recurrent IDH-WT glioblastoma.Semantic proximity Read ↗

Predictors of Survival in Turkish Patients with Primary Glioblastoma.Semantic proximity Read ↗

Establishment and characteristics of GWH04, a new primary human glioblastoma cell lineSemantic proximity Read ↗

Differential Predictors and Clinical Implications Associated With Long-Term Survivors in IDH Wildtype and Mutant GlioblastomaSemantic proximity Read ↗

Genetics of Glioma Progression and the Definition of Primary and Secondary GlioblastomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.